Pharmagest Interactive Societe Anonyme Reports Unaudited Sales Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Year 2013 and 2014
The structure of the PHARMAGEST Group's turnover in 2013 as well as the 100% integration in fourth quarter of its subsidiary HEALTHLEASE FRANCE makes it possible to anticipate a profit in 2013 as well as profitability that is increasing and greater than projected.
For 2014, the PHARMAGEST Group already expects a significant impact on its Laboratories business as a result of regulatory changes. The decrease in turnover with low profit margin of this activity (Communication services), however, will have a mitigated effect on the operating income of the PHARMAGEST Group.